- Report
- October 2024
- 195 Pages
Global
From €3226EUR$3,545USD£2,766GBP
€3585EUR$3,939USD£3,073GBP
- Report
- August 2024
- 139 Pages
Global
From €2729EUR$2,999USD£2,340GBP
- Report
- April 2025
- 200 Pages
Global
From €4086EUR$4,490USD£3,503GBP
- Report
- March 2024
- 180 Pages
Global
From €5415EUR$5,950USD£4,642GBP
- Report
- February 2024
- 182 Pages
Global
From €4095EUR$4,500USD£3,511GBP
- Report
- February 2024
- 132 Pages
Global
From €4323EUR$4,750USD£3,706GBP
- Report
- April 2024
- 124 Pages
Global
From €3595EUR$3,950USD£3,082GBP
- Report
- October 2023
- 146 Pages
Global
From €3777EUR$4,150USD£3,238GBP
- Report
- October 2024
Global
From €3185EUR$3,500USD£2,731GBP
The Prolactin Test is a type of In Vitro Diagnostic (IVD) used to measure the amount of prolactin in a patient's blood. Prolactin is a hormone produced by the pituitary gland and is important for lactation, fertility, and other bodily functions. The Prolactin Test is used to diagnose and monitor conditions such as hyperprolactinemia, hypopituitarism, and pituitary tumors. It is also used to monitor the effectiveness of medications used to treat these conditions.
The Prolactin Test market is a subset of the larger IVD market, which is estimated to be worth billions of dollars. The Prolactin Test market is expected to grow in the coming years due to the increasing prevalence of conditions such as hyperprolactinemia and hypopituitarism.
Some companies in the Prolactin Test market include Abbott Laboratories, Siemens Healthineers, Roche Diagnostics, and Thermo Fisher Scientific. Show Less Read more
